Logo image of CY4.MI

CY4GATE SPA (CY4.MI) Stock Fundamental Analysis

BIT:CY4 - Euronext Milan - IT0005412504 - Common Stock - Currency: EUR

5.41  +0.18 (+3.44%)

Fundamental Rating

3

Overall CY4 gets a fundamental rating of 3 out of 10. We evaluated CY4 against 103 industry peers in the Software industry. While CY4 seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, CY4 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CY4 had negative earnings in the past year.
CY4 had a positive operating cash flow in the past year.
In multiple years CY4 reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CY4 reported negative operating cash flow in multiple years.
CY4.MI Yearly Net Income VS EBIT VS OCF VS FCFCY4.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

CY4 has a worse Return On Assets (-9.19%) than 74.76% of its industry peers.
CY4 has a Return On Equity of -17.68%. This is in the lower half of the industry: CY4 underperforms 74.76% of its industry peers.
Industry RankSector Rank
ROA -9.19%
ROE -17.68%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CY4.MI Yearly ROA, ROE, ROICCY4.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

CY4 has a worse Gross Margin (48.18%) than 67.96% of its industry peers.
In the last couple of years the Gross Margin of CY4 has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CY4 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.65%
GM growth 5Y-0.54%
CY4.MI Yearly Profit, Operating, Gross MarginsCY4.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

CY4 does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for CY4. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CY4.MI Yearly Shares OutstandingCY4.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
CY4.MI Yearly Total Debt VS Total AssetsCY4.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.17, we must say that CY4 is in the distress zone and has some risk of bankruptcy.
CY4's Altman-Z score of 1.17 is on the low side compared to the rest of the industry. CY4 is outperformed by 68.93% of its industry peers.
CY4 has a debt to FCF ratio of 5.51. This is a neutral value as CY4 would need 5.51 years to pay back of all of its debts.
CY4 has a Debt to FCF ratio (5.51) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.29 indicates that CY4 is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.29, CY4 perfoms like the industry average, outperforming 53.40% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.51
Altman-Z 1.17
ROIC/WACCN/A
WACC9.43%
CY4.MI Yearly LT Debt VS Equity VS FCFCY4.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

CY4 has a Current Ratio of 1.61. This is a normal value and indicates that CY4 is financially healthy and should not expect problems in meeting its short term obligations.
CY4 has a Current ratio of 1.61. This is in the better half of the industry: CY4 outperforms 66.99% of its industry peers.
A Quick Ratio of 1.59 indicates that CY4 should not have too much problems paying its short term obligations.
CY4 has a Quick ratio of 1.59. This is in the better half of the industry: CY4 outperforms 68.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.59
CY4.MI Yearly Current Assets VS Current LiabilitesCY4.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.72% over the past year.
CY4 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.37%.
Measured over the past years, CY4 shows a very strong growth in Revenue. The Revenue has been growing by 59.24% on average per year.
EPS 1Y (TTM)21.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.3%
Revenue 1Y (TTM)13.37%
Revenue growth 3Y61.94%
Revenue growth 5Y59.24%
Sales Q2Q%9.32%

3.2 Future

CY4 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.61% yearly.
Based on estimates for the next years, CY4 will show a small growth in Revenue. The Revenue will grow by 7.63% on average per year.
EPS Next Y52.91%
EPS Next 2Y47.05%
EPS Next 3Y43.61%
EPS Next 5YN/A
Revenue Next Year7.97%
Revenue Next 2Y2.57%
Revenue Next 3Y7.63%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CY4.MI Yearly Revenue VS EstimatesCY4.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CY4.MI Yearly EPS VS EstimatesCY4.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CY4 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 132.26, CY4 can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, CY4 is valued a bit more expensive than 62.14% of the companies in the same industry.
CY4's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.15.
Industry RankSector Rank
PE N/A
Fwd PE 132.26
CY4.MI Price Earnings VS Forward Price EarningsCY4.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CY4 is valued a bit more expensive than the industry average as 64.08% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CY4 indicates a rather cheap valuation: CY4 is cheaper than 84.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.56
EV/EBITDA 56
CY4.MI Per share dataCY4.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CY4 does not grow enough to justify the current Price/Earnings ratio.
CY4's earnings are expected to grow with 43.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.05%
EPS Next 3Y43.61%

More info and screens

0

5. Dividend

5.1 Amount

CY4 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CY4GATE SPA

BIT:CY4 (5/30/2025, 9:41:49 AM)

5.41

+0.18 (+3.44%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners13.64%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap127.51M
Analysts86.67
Price Target5.66 (4.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-327.27%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 132.26
P/S 1.25
P/FCF 15.56
P/OCF 10.82
P/B 1.29
P/tB 7.12
EV/EBITDA 56
EPS(TTM)-0.68
EYN/A
EPS(NY)0.04
Fwd EY0.76%
FCF(TTM)0.35
FCFY6.43%
OCF(TTM)0.5
OCFY9.24%
SpS4.34
BVpS4.2
TBVpS0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.19%
ROE -17.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.18%
FCFM 8.01%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.65%
GM growth 5Y-0.54%
F-ScoreN/A
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.51
Debt/EBITDA 10.26
Cap/Depr 17.12%
Cap/Sales 3.5%
Interest Coverage N/A
Cash Conversion 422.73%
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 1.59
Altman-Z 1.17
F-ScoreN/A
WACC9.43%
ROIC/WACCN/A
Cap/Depr(3y)19.8%
Cap/Depr(5y)17.04%
Cap/Sales(3y)4.99%
Cap/Sales(5y)3.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.3%
EPS Next Y52.91%
EPS Next 2Y47.05%
EPS Next 3Y43.61%
EPS Next 5YN/A
Revenue 1Y (TTM)13.37%
Revenue growth 3Y61.94%
Revenue growth 5Y59.24%
Sales Q2Q%9.32%
Revenue Next Year7.97%
Revenue Next 2Y2.57%
Revenue Next 3Y7.63%
Revenue Next 5YN/A
EBIT growth 1Y-32.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3400%
EBIT Next 3Y258.31%
EBIT Next 5YN/A
FCF growth 1Y-50.75%
FCF growth 3YN/A
FCF growth 5Y87.64%
OCF growth 1Y-42.43%
OCF growth 3YN/A
OCF growth 5Y43.36%